Life Science Success

Send us Fan Mail

In this episode of the Life Science Success Podcast, my guest is Artem Britchenko.  Artem is the CEO of Platforce, which helps companies that interact with healthcare professionals and care about the efficiency and compliance of these interactions. He has been working in the B2C Pharma industry, helping companies improve their sales force effectiveness, customer engagement, and customer centricity.

• Don Davis, PhD, MBA interviews Artem Brytchenko, CEO of Platforce
• Platforce is a CRM solution tailored to the unique needs of the life sciences industry
• The solution includes closed loop marketing, remote capabilities, consent collection, distributor order optimization, and more
• The biggest challenges faced by Platforce include constant innovation and adaptation, scaling operations, and managing a global, distributed team
• The biggest opportunities include the rapid digital transformation of the life sciences industry, expanding to new geographies and markets, and serving adjacent sectors within healthcare
• Artem is inspired by his team, challenges, and family, concerned about the rapidly changing technological landscape and global complexities, and excited about fostering innovation and collaboration, technological advancements, and personal growth and happiness

Send us Fan Mail

In this episode of Life Science Success, my guest is Rohit Sood  EVP, COMPLETE Commercialization at EVERSANA.  He is a life sciences strategy and operations executive with a passion for developing teams and solving business challenges. Track record of driving topline business growth while identifying significant operational efficiencies in PE-backed, startup, and publicly-listed organizations.

• Rohit Sood and Don Davis discuss challenges faced by organizations during the commercialization phase
• Eversana helps smaller biotechs evaluate the process of commercialization and provides support through it
• Good leadership inspires Rohit, and he values transparency and clarity in decision-making
• Short-term thinking and not listening to advisors concerns Rohit
• Traveling and food excite Rohit

Send us Fan Mail

In this episode of Life Science Success, I am joined by Daniel Thadani the Head of Retail and Tenders for IPCA Laboratories Limited.  Daniel is based in Kyiv, Ukraine 🇺🇦.  He is responsible for  business promotion and development, sales forecasting, distribution management, marketing coordination with head office, pricing, product registration through a third party, team hiring, and management.

• Daniel Thadani worked as a country head in Kazakhstan for five and a half years
• He describes the differences in medical affairs, regulatory, people management, distribution, and the overall landscape of pharma in Central Asia
• Thadani emphasizes the importance of trust and integrity in leadership
• He works for IPCA Laboratories, a top-notch pharma company that produces branded generic products with 350 formulations and 80 APIs in various therapeutic areas
• IPCA has a solid footprint in Africa, South America, and Southeast Asia and is a world leader in APIs
• Thadani discusses the resilience of the pharma business in Ukraine during the COVID-19 pandemic and war
• He is concerned about indecency and political approaches in people, as well as discrepancies in numbers
• Thadani is excited by complex situations with a positive impact on his immediate ecosystem

Send us Fan Mail

In this episode of Life Science Success, my guest is Nusqe Spanton.  Nusqe is the founder and CEO of Provectus Algae. He is an aquaculture and algae expert with nearly two decades of experience working in international aquacultural production, marine biotechnology, and corporate management.

• Nusqe Spanton discusses the potential of marine microorganisms to produce commercially valuable compounds.
• The company, Provectus, is focused on developing products for food, agriculture, and cosmetics, as well as oral fertility treatments.
• The company is still in an early phase of development and has around 30 employees.
• Spanton emphasizes the importance of making quick and decisive decisions as a leader, especially in a startup environment.
• He also stresses the need to move quickly in addressing environmental concerns.
• Spanton is inspired by his children and the potential of the younger generation to effect change.
• He is excited about building a great business with like-minded individuals and being a problem solver.

Send us Fan Mail

In this episode of Life Science Success, my guest is John Alderete. Dr. Alderete has successfully applied his wide range of experience and formal training to the evaluation, financing, formation, and operation of diagnostics and medical device technology companies.

• Don Davis and John Alderete discuss pitching scientific research to investors
• Davis emphasizes tailoring pitches to the audience and understanding investors' perspective
• Alderete stresses the importance of having the right team and being honest about limitations
• Alderete expresses concern about lack of progress in biological surveillance and potential for future pandemics
• Alderete is excited about modern tools and technologies available to younger generation of scientists
• The conversation offers insights on challenges of pitching research, importance of team, and need for better pandemic preparation
• It highlights exciting possibilities in modern tools and technologies for younger scientists.

Send us Fan Mail

In this episode of Life Science Success, my guest is Dr. Helen Torley.  Dr. Torley is the President and CEO of Halozyme. Halozyme's innovative and disruptive solutions provide new therapeutic options that could significantly improve the patient experience by changing how treatments are delivered. 

• Dr. Helen Torley, CEO of Halozyme, discusses the company's dedication to improving patient experiences and outcomes through their research and development of monoclonal antibodies and small molecules.
• Halozyme places a strong emphasis on corporate culture, including cross-functional collaboration and community outreach.
• Dr. Torley shares how the book "The Five Dysfunctions of a Team" has influenced her leadership style.
• Dr. Torley is inspired by the innovative ideas and enthusiasm of her team members.
• She expresses concern about the impact of remote work on creativity, problem-solving, and personal development.
• The company is focused on putting patients at the center of their mission.
• They have a strong focus on community outreach, with 70% employee participation in volunteering events.
• She shares a personal story about a family member's experience with cancer treatment to underscore the importance of improving patient experiences.
• This episode of the Life Science Success podcast provides insight into the innovative solutions Halozyme is developing and their commitment to patient-centered care.

Send us Fan Mail

In this episode of Life Science Success my guest is Kristofer Mussar.   Kristofer graduated from University of Georgia with a PhD in Molecular Genetics where he focused on Epigenetics and Evolution. He simultaneously obtained his MBA from the Terry College of Business.  He is currently the Managing Director and COO of VectorBuilder Inc.

• Kristofer Mussar, PhD, discusses his company Vector Builder and their innovative gene delivery methods.
• Vector Builder's platform is free to use and includes a design team for gene delivery methods.
• They are working on several R&D projects, including a capsid evolution for novel capsids, a bacterial backbone-free plasmid, and antibody-conjugated lipo nanoparticles with mRNA.
• Vector Builder emphasizes collaboration and treating researchers as collaborators.
• Mussar believes in the importance of genetics and personalized medicine.
• Vector Builder has a new software-based platform called Vector B in development.

Send us Fan Mail

In this episode of Life Science Success my guests are Rahul Sharma, the co-founder and CSO of Scienetix, a company dedicated to enabling Molecular Diagnosis. Dr. Sharma is a board-certified laboratory director and technical lead for Next Generation Sequencing (NGS) and PCR-based assay development and clinical testing. He has developed multiple Molecular Diagnosis tests and translated them into clinical testing. 

Additionally, We are joined by Rob Carpenter PhD, MBA the CEO of Scienetix.  Rob is a healthcare executive and educator with over 25 years’ experience in developing, managing, and assimilating healthcare companies. He is distinctly skilled in business development and various business growth strategies. He is founder and current CEO of Advanta Genetics, a highly complex clinical and research laboratory accredited by the College of American Pathologists with concentration in infectious disease molecular genomics and Scienetix, a bioscientific company centered around products to optimize molecular genomic
workflows.

• In the podcast, Dr. Sharma and Dr. Carpenter talk about the healthcare industry's need to optimize workflow and reduce costs in laboratory testing.
• Their company, Scienetix, is working on developing extraction-free tests that will eliminate the need for sample pre-processing and make testing more accessible and cheaper for labs.
• They are also focused on increasing the multiplex capability of PCR reactions, which will allow labs to test for more targets in a single reaction.
• Dr. Sharma and Dr. Carpenter also discuss their leadership styles and offer advice on being reliable, thinking about the application of science, and staying creative.
• They express concern about the growing distrust of science and the spread of misinformation, particularly in the age of social media.
• What excites them most is the opportunity to solve scientific challenges and create products that have a societal impact.

Send us Fan Mail

In this episode of Life Sciences Success, my guest is Sharon Rogers the CEO of AmyriAD.  Sharon brings the strength of her 35 years of pharmaceutical experience to AmyriAD. She is best known as the worldwide leader and development strategist for the highly successful AD treatment, Aricept. Aricept has been the standard of care for more than 20 years, and no other AD program has produced more compelling results.

• Sharon L. Rogers, a research scientist, talks about a new drug for Alzheimer's disease
• The drug, AD101, is designed to improve cognition and global function in Alzheimer's patients
• It is a cholinergic drug, but its action is limited to the brain, making it more effective than other cholinergic drugs
• The drug has gone through phase two trials and is now moving into phase three
• Rogers also discusses her experience as an expat in Japan and the importance of resilience and leadership
• She expresses concern about complacency and outrage fatigue
• Rogers is excited about the potential of Gen Z to effect change

Send us Fan Mail

Today on the Life Science Success podcast my guest is Sal Buscemi.  Sal is a notable figure in the world of finance and real estate, has made a name for himself through his impressive portfolio of investments and his leadership roles in various investment offices. Currently serving as the CEO and Co-Founding Partner of HRN, a private multi-family investment office, as well as the CEO for Dandrew Partners Capital Management.

• Sal Buscemi discusses the importance of understanding the science and evaluating user feedback effectively
• He advises making investment opportunities attractive to investors, as they are unlikely to focus on the math
• Sal emphasizes the significance of building relationships and networking, as it is important for building a brand and reputation
• He expresses concerns about the potential destabilization of the petro dollar and the impact it might have on the strength of the country
• Sal mentions that he enjoys building things, meeting new people, and making an impact in the life sciences industry